Search research articles
Contact Us
Filters
Showing results (171-180 of 199) with videos related to
Page
of 20
Sort By:
Scientific Reports
|
May 19, 2016
Targeting membrane proteins for antibody discovery using phage display
Martina L Jones, Mohamed A Alfaleh, Sumukh Kumble, et al.
Trials
|
February 12, 2020
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)
Michelle L M Mulder, Johanna E Vriezekolk, Nathan den Broeder, et al.
Communications Biology
|
March 24, 2021
Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product
Lucia F Zacchi, Dinora Roche-Recinos, Cassandra L Pegg, et al.
Clinical and Experimental Rheumatology
|
October 10, 2018
Short-term clinical worsening is a clear predictor for worsening at 2 years in established knee and hip osteoarthritis
Elien A M Mahler, Alfons A den Broeder, Nathan den Broeder, et al.
International Journal of Molecular Sciences
|
August 12, 2022
Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies
Nadya Panagides, Lucia F Zacchi, Mitchell J De Souza, et al.
The Lancet. Rheumatology
|
January 23, 2024
Long-term efficacy of low-dose radiation therapy on symptoms in patients with knee and hand osteoarthritis: follow-up results of two parallel randomised, sham-controlled trials
Cornelia H M van den Ende, Michiel J M Minten, Mathilde M Leseman-Hoogenboom, et al.
ACS Nano
|
September 16, 2020
Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and Targeting
Amal J Sivaram, Andri Wardiana, Sheilajen Alcantara, et al.
Lab on a Chip
|
November 13, 2019
Retooling phage display with electrohydrodynamic nanomixing and nanopore sequencing
Lyndon J Raftery, Christopher B Howard, Yadveer S Grewal, et al.
Advanced Healthcare Materials
|
June 11, 2016
Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies
Christopher B Howard, Nicholas Fletcher, Zachary H Houston, et al.
Annals of the Rheumatic Diseases
|
February 3, 2019
Response to: 'Is it time to redefine the role of low-dose radiotherapy for benign disease?' by Montero <i>et al</i>
Elien A M Mahler, Michiel Jm Minten, Mathilde M Leseman-Hoogenboom, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 199) with videos related to
Sort By:
Page
of 20
Scientific Reports
|
May 19, 2016
Targeting membrane proteins for antibody discovery using phage display
Martina L Jones, Mohamed A Alfaleh, Sumukh Kumble, et al.
Trials
|
February 12, 2020
Comparing methotrexate monotherapy with methotrexate plus leflunomide combination therapy in psoriatic arthritis: protocol of a randomized, placebo-controlled, double-blind clinical trial (COMPLETE-PsA)
Michelle L M Mulder, Johanna E Vriezekolk, Nathan den Broeder, et al.
Communications Biology
|
March 24, 2021
Coagulation factor IX analysis in bioreactor cell culture supernatant predicts quality of the purified product
Lucia F Zacchi, Dinora Roche-Recinos, Cassandra L Pegg, et al.
Clinical and Experimental Rheumatology
|
October 10, 2018
Short-term clinical worsening is a clear predictor for worsening at 2 years in established knee and hip osteoarthritis
Elien A M Mahler, Alfons A den Broeder, Nathan den Broeder, et al.
International Journal of Molecular Sciences
|
August 12, 2022
Evaluation of Phage Display Biopanning Strategies for the Selection of Anti-Cell Surface Receptor Antibodies
Nadya Panagides, Lucia F Zacchi, Mitchell J De Souza, et al.
The Lancet. Rheumatology
|
January 23, 2024
Long-term efficacy of low-dose radiation therapy on symptoms in patients with knee and hand osteoarthritis: follow-up results of two parallel randomised, sham-controlled trials
Cornelia H M van den Ende, Michiel J M Minten, Mathilde M Leseman-Hoogenboom, et al.
ACS Nano
|
September 16, 2020
Controlling the Biological Fate of Micellar Nanoparticles: Balancing Stealth and Targeting
Amal J Sivaram, Andri Wardiana, Sheilajen Alcantara, et al.
Lab on a Chip
|
November 13, 2019
Retooling phage display with electrohydrodynamic nanomixing and nanopore sequencing
Lyndon J Raftery, Christopher B Howard, Yadveer S Grewal, et al.
Advanced Healthcare Materials
|
June 11, 2016
Overcoming Instability of Antibody-Nanomaterial Conjugates: Next Generation Targeted Nanomedicines Using Bispecific Antibodies
Christopher B Howard, Nicholas Fletcher, Zachary H Houston, et al.
Annals of the Rheumatic Diseases
|
February 3, 2019
Response to: 'Is it time to redefine the role of low-dose radiotherapy for benign disease?' by Montero <i>et al</i>
Elien A M Mahler, Michiel Jm Minten, Mathilde M Leseman-Hoogenboom, et al.
Page
of 20